Table 3.
CpG | Chr | Position (bp) | Probe SNPs | Probe SNPs 10 | Gene | Gene region | PEG1 - blood DNA (n = 579) |
PEG2 - saliva DNA (n = 231) |
||
---|---|---|---|---|---|---|---|---|---|---|
cor | p value | cor | p value | |||||||
cg19952704 | 4 | 187,751,549 | −0.23 | 1.67E−08 | −0.24 | 2.10E−04 | ||||
cg05995465 | 2 | 240,313,602 | rs6147245 | HDAC4 | 5′UTR | 0.21 | 4.28E−07 | 0.22 | 7.02E−04 | |
cg06193597 | 2 | 241,896,910 | rs10173220 | −0.21 | 4.22E−07 | −0.22 | 8.75E−04 | |||
cg08354527 | 1 | 229,252,042 | rs2125454 | −0.21 | 3.12E−07 | −0.22 | 9.42E−04 | |||
cg21598190 | 7 | 2,099,404 | rs6953670 | MAD1L1 | Body | 0.22 | 1.09E−07 | 0.21 | 1.44E−03 | |
cg12856521 | 11 | 46,389,249 | rs34470543 | DGKZ | Body | −0.23 | 4.41E−08 | −0.21 | 1.57E−03 | |
cg22996768 | 19 | 33,719,749 | −0.23 | 2.17E−08 | 0.20 | 1.79E−03 | ||||
cg02059823 | 2 | 240,872,433 | rs73101773 | 0.23 | 3.70E−08 | 0.19 | 3.98E−03 | |||
cg15680603 | 6 | 33,037,413 | rs1126542 | rs35171346 | HLA-DPA1 | Body | 0.20 | 7.94E−07 | 0.16 | 1.42E−02 |
cg11927033 | 6 | 122,793,073 | rs3752576 | PKIB; SERINC1 | 1st exon; 5′UTR; TSS200 | 0.25 | 1.14E−09 | 0.16 | 1.49E−02 | |
cg15145296 | 3 | 125,709,740 | 0.21 | 3.49E−07 | 0.16 | 1.84E−02 | ||||
cg14044167 | 8 | 134,271,505 | NDRG1 | Body | 0.22 | 9.91E−08 | −0.15 | 1.86E−02 | ||
cg17858192 | 4 | 16,077,807 | PROM1 | TSS200; TSS200; 5′UTR | −0.23 | 2.51E−08 | 0.14 | 3.04E−02 | ||
cg15138543 | 4 | 987,391 | rs3806756 | IDUA; SLC26A1 | Body; TSS1500; TSS200 | −0.20 | 8.12E−07 | −0.13 | 5.15E−02 |
Chr Chromosome, bp base pair, TSS transcription start site, TSS1500 within 1500 bps of a TSS, TSS200 within 200 bps of a TSS, UTR untranslated region, SNPs listing dbSNP entries within a probe, SNPs_10 listing dbSNP entries within 10 bp of the CpG site.
These are CpGs with p values < 0.05 from saliva DNA methylation replication analyses; adjusting for PD, age, sex, and European ancestry.
Blood-based DNA population (PEG1) and saliva-based DNA population (PEG2) are comprised of different participants.